Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: opalapril who wrote (6963)	8/20/1998 6:18:00 PM
From: aknahow	Read Replies (1) \| Respond to of 17367

Opala, relax, price action stinks , for sure but most jobs are new positions. Ellen is not leaving but her assistant is. I have suggested to XOMA to designate positions as new, when they are and with no label when they are replacements. I do not know what the downside of this would be for recruitment. I do not necessarily expect they will use my suggestion, so I am just informing you and other that I agree that there is some confusion as to who is coming and going, under the current disclosure situation. BTW I have asked friends to help me understand the implications of BPI in the lipid transfer function in relation to cholesteryl ester transfer protein. An article will be appearing in Current Opinion of Structural Biology. Note some other non BPI related to get at least an idea of what might be involved. 49. McPherson, R., Agnani, G., Lau, P., Fruchart, J-C., Edgar, A.D. and Marcel Y.L. Role of LpA-I and LpA-I/A-II in cholesteryl ester transfer protein- mediated neutral lipid transfer. Arteriosclerosis, Thrombosis and Vascular Biology, 1996;16:1340-1346.